INBX EBITDA
Inhibrx Biosciences Inc · EBITDA
INBX EBITDA
Latest reported-$120.45Mperiod ending
INBX TTM EBITDA (-$26.86M → -$120.45M)
TTM EBITDA
High-resolution chart · PNG
INBX ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -120,449,000 | |
| -114,822,000 | |
| -125,374,000 | |
| -143,465,000 | |
| -155,077,000 | |
| 1,733,623,000 | |
| 1,703,350,000 | |
| 1,662,535,000 | |
| 1,662,305,000 | |
| -240,393,000 | |
| -211,231,000 | |
| -158,438,000 | |
| -144,798,000 | |
| -140,223,000 | |
| -127,838,000 | |
| -111,737,000 | |
| -100,546,000 | |
| -85,771,000 | |
| -75,349,000 | |
| -73,101,000 | |
| -70,156,000 | |
| -67,581,000 | |
| -66,675,000 | |
| -66,343,000 | |
| -66,856,000 | |
| -54,299,000 | |
| -39,790,000 | |
| -27,156,000 | |
| -17,581,000 | |
| -21,933,000 | |
| -26,858,000 |